4.5 Article

β-Amyloid impairs axonal BDNF retrograde trafficking

Journal

NEUROBIOLOGY OF AGING
Volume 32, Issue 5, Pages 821-833

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.neurobiolaging.2009.05.012

Keywords

beta-Amyloid; Alzheimer; BDNF; Neurotrophin; Axonal transport; Microfluidic chamber

Funding

  1. NIH [AG00538, AGO 16573, AG000096, AG029378]

Ask authors/readers for more resources

The neurotrophin, brain-derived neurotrophic factor (BDNF), is essential for synaptic function, plasticity and neuronal survival. At the axon terminal, when BDNF binds to its receptor, tropomyosin-related kinase B (TrkB), the signal is propagated along the axon to the cell body, via retrograde transport, regulating gene expression and neuronal function. Alzheimer disease (AD) is characterized by early impairments in synaptic function that may result in part from neurotrophin signaling deficits. Growing evidence suggests that soluble beta-amyloid (A beta) assemblies cause synaptic dysfunction by disrupting both neurotransmitter and neurotrophin signaling. Utilizing a novel microfluidic culture chamber, we demonstrate a BDNF retrograde signaling deficit in AD transgenic mouse neurons (Tg2576) that can be reversed by gamma-secretase inhibitors. Using BDNF-GFP, we show that BDNF-mediated TrkB retrograde trafficking is impaired in Tg2576 axons. Furthermore, A beta oligomers alone impair BDNF retrograde transport. Thus, A beta reduces BDNF signaling by impairing axonal transport and this may underlie the synaptic dysfunction observed in AD. Published by Elsevier Inc.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available